The utility of peripheral stereopsis

This perspective article makes the case for evaluating and training peripheral stereopsis, particularly when the central visual field is compromised in one or both eyes. Examples of clinical conditions that preferentially affect the central visual field include macular degeneration, which affects the central macular region in one or both eyes, and amblyopia where the central field is often affected in one eye, but the peripheral field is largely intact. While binocular acuity may be preserved when the monocular central field of one eye is affected, fine stereopsis is compromised because it requires intact vision in corresponding locations in the two eyes. Even in these clinical conditions, recent studies that map stereoacuity at locations across the visual field demonstrate that the periphery supports coarse stereopsis, and that training efforts to use residual stereopsis may have greater benefit if they take this finding into account.

Mapping residual stereopsis in macular degeneration

Individuals with macular degeneration typically lose vision in the central region of one or both eyes. A binocular scotoma occurs when vision loss occurs in overlapping locations in both eyes, but stereopsis is impacted even in the non-overlapping region wherever the visual field in either eye is affected. We used a novel stereoperimetry protocol to measure local stereopsis across the visual field (up to 25° eccentricity) to determine how locations with functional stereopsis relate to the scotomata in the two eyes. Participants included those with monocular or binocular scotomata and age-matched controls with healthy vision. Targets (with or without depth information) were presented on a random dot background. Depth targets had true binocular disparity of 20' (crossed), whereas non-depth targets were defined by monocular cues such as contrast and dot density. Participants reported target location and whether it was in depth or flat. Local depth sensitivity (d') estimates were then combined to generate a stereopsis map. This stereopsis map was compared to the union of the monocular microperimetry estimates that mapped out the functional extent of the scotoma in each eye. The "union" prediction aligned with residual stereopsis, showing impaired stereopsis within this region and residual stereopsis outside this region. Importantly, the stereoblind region was typically more extensive than the binocular scotoma defined by the intersection (overlap) of the scotomata. This explains why individuals may have intact binocular visual fields but be severely compromised in tasks of daily living that benefit from stereopsis, such as eye-hand coordination and navigation.

Macular Thickness and Microvasculature Loss in Glaucoma Suspect Eyes

PURPOSE

To characterize the change of ganglion cell complex (GCC) thickness and macular vessel density in glaucoma suspect eyes with ocular hypertension (OHT) or glaucomatous optic neuropathy (GON).

DESIGN

Prospective, longitudinal study.

PARTICIPANTS

Eight-three eyes (24 healthy, 30 OHT, and 29 GON) of 65 patients who underwent at least 3 visits were included from the Diagnostic Innovations in Glaucoma Study. The mean follow-up was at least 3 years.

METHODS

OCT angiography (OCTA)-based vessel density and OCT-based structural thickness of the 3 × 3-mm¹ GCC scan slab were evaluated at each visit. The rates of vessel density and thickness change were compared across diagnostic groups using a linear mixed-effects model.

MAIN OUTCOME MEASURES

Change rates of macula GCC thickness and superficial vessel density.

RESULTS

Significant mean rates of both GCC thinning and vessel density loss were detectable in OHT and GON groups. Of the individual suspect eyes, 49.1% showed significant loss (P < 0.05) with either vessel density or GCC thickness. Of the GON eyes, 31.0% showed both significant GCC loss and vessel density loss, 51.7% showed only significant GCC loss, whereas 17.2% showed only significant vessel density loss. Vessel density loss was faster than GCC thinning in half of the suspect eyes based on percent loss analysis. The age and scan quality-adjusted GCC thinning rates of the OHT group (-0.59 μm/year; P = 0.025) and GON group (-0.79 μm/year; P = 0.058) were faster than those of the healthy group (-0.11 μm/year), whereas the rate of vessel density loss was not significantly different among the diagnostic groups (all P > 0.2). Higher mean intraocular pressure during follow-up was associated with faster GCC thinning in the OHT group (P = 0.065) and GON groups (P = 0.015), but was not associated with the rate of vessel density decrease.

CONCLUSIONS

Whereas the rate of GCC thinning was faster on average in suspect eyes than in healthy eyes, some suspect eyes showed significant loss of vessel density and faster vessel density loss than GCC thinning. OCT and OCTA are complementary and useful for evaluating eyes with OHT or GON.